2/9
09:00 am
codx
Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai
Medium
Report
Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai
2/5
09:00 am
codx
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
Low
Report
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
2/4
09:00 am
codx
Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform
Neutral
Report
Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform
1/24
03:01 am
codx
Co-Diagnostics (NASDAQ:CODX) was downgraded by analysts at
Wall Street Z
Low
Report
Co-Diagnostics (NASDAQ:CODX) was downgraded by analysts at
Wall Street Z
1/23
01:34 pm
codx
Co-Diagnostics (NASDAQ:CODX) had its "hold" rating reaffirmed by analysts at Maxim Group.
Low
Report
Co-Diagnostics (NASDAQ:CODX) had its "hold" rating reaffirmed by analysts at Maxim Group.
1/12
09:12 am
codx
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships [Yahoo! Finance]
Medium
Report
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships [Yahoo! Finance]
1/12
09:00 am
codx
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships
Low
Report
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships
1/3
01:06 am
codx
Medium
Report
12/30
09:26 am
codx
Co-Diagnostics announces 1-for-30 reverse stock split [Seeking Alpha]
Low
Report
Co-Diagnostics announces 1-for-30 reverse stock split [Seeking Alpha]
12/30
09:00 am
codx
Co-Diagnostics Announces Reverse Stock Split
Medium
Report
Co-Diagnostics Announces Reverse Stock Split
12/29
09:22 am
codx
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies [Yahoo! Finance]
Low
Report
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies [Yahoo! Finance]
12/29
09:00 am
codx
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
Low
Report
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
12/18
09:34 am
codx
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India [Yahoo! Finance]
Low
Report
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India [Yahoo! Finance]
12/18
09:00 am
codx
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
Low
Report
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
12/17
09:00 am
codx
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation
Low
Report
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation
12/9
09:00 am
codx
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
Medium
Report
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
12/8
12:36 pm
codx
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
Low
Report
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
11/26
10:09 am
codx
Co-Diagnostics (NASDAQ:CODX) was upgraded by analysts at Maxim Group to a "hold" rating.
Medium
Report
Co-Diagnostics (NASDAQ:CODX) was upgraded by analysts at Maxim Group to a "hold" rating.
11/26
08:46 am
codx
Co-Diagnostics (NASDAQ:CODX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $1.50 price target on the stock.
High
Report
Co-Diagnostics (NASDAQ:CODX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $1.50 price target on the stock.
11/24
08:06 am
codx
Co-Diagnostics (NASDAQ:CODX) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Co-Diagnostics (NASDAQ:CODX) had its "neutral" rating reaffirmed by analysts at HC Wainwright.